Anti-Obesity Effect of a Tea Mixture Nano-Formulation on Rats Occurs via the Upregulation of AMP-Activated Protein Kinase/Sirtuin-1/Glucose Transporter Type 4 and Peroxisome Proliferator-Activated Receptor Gamma Pathways

• Published in: Metabolites 2023-07, Vol.13 (7), p.871
• Main Authors: Salem, Mohamed A, Aborehab, Nora M, Abdelhafez, Mai M, Ismail, Sameh H, Maurice, Nadine W, Azzam, May A, Alseekh, Saleh, Fernie, Alisdair R, Salama, Maha M, Ezzat, Shahira M
• Format: Article
• Language: English
• Subjects: Acarbose; Adenylic acid; Adipogenesis; AMP-activated protein kinase; Biological activity; catechins; Gene expression; Glucose transporter; green tea; Health aspects; Inflammation; Insulin resistance; Ions; Kinases; Lipase; Lipolysis; Metabolic disorders; Metabolomics; Nanoparticles; Obesity; oolong tea; Peroxisome proliferator-activated receptors; Physiological aspects; Prevention; Properties; Protein kinases; Protein transport; Serum levels; Sterol regulatory element-binding protein; Tea; Triglycerides; Tumor necrosis factor-α; white tea; α-Amylase
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo13070871

White, green, and oolong teas are produced from the tea plant ( (L.) Kuntze) and are reported to have anti-obesity and hypolipidemic effects. The current study aims to investigate the anti-obesity effects of a tea mixture nano-formulation by targeting the AMPK/Sirt-1/GLUT-4 axis in rats. In vitro lipase and -amylase inhibition assays were used to determine the active sample, which was then incorporated into a nanoparticle formulation subjected to in vivo anti-obesity testing in rats by measuring the expression level of different genes implicated in adipogenesis and inflammation using qRT-PCR. Moreover, metabolomic analysis was performed for each tea extract using LC/ESI MS/MS coupled to chemometrics in an attempt to find a correlation between the constituents of the extracts and their biological activity. The in vitro pancreatic lipase and -amylase inhibition assays demonstrated more effective activity in the tea mixture than the standards, orlistat and acarbose, respectively, and each tea alone. Thus, the herbal tea mixture and its nanoparticle formulation were evaluated for their in vivo anti-obesity activity. Intriguingly, the tea mixture significantly decreased the serum levels of glucose and triglycerides and increased the mRNA expression of GLUT-4, P-AMPK, Sirt-1, and PPAR-γ, which induce lipolysis while also decreasing the mRNA expression of TNF-α and ADD1/SREBP-1c, thereby inhibiting the inflammation associated with obesity. Our study suggests that the tea mixture nano-formulation is a promising therapeutic agent in the treatment of obesity and may also be beneficial in other metabolic disorders by targeting the AMPK/Sirt-1/Glut-4 pathway.